Publication | Open Access

Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell Carcinoma: a prospective evaluation

UrologyGenitourinary CancerMedicineProspective EvaluationCombination TherapyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyMolecular Oncology